Skip to main content
Equibles
SUPN $42.18 -2.00%
SUPN logo
SUPN · Supernus Pharmaceuticals, Inc.
Track SUPN — free

Use SUPN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SUPN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$42.18 -0.86 (-2.00%) At close · Oct 1
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$2.48B
Shares
58.13M
Volume · Oct 1 424.63K Avg daily vol (3M) 781.5K
All webcasts

Earnings call · FY2020 Q1

Supernus Pharmaceuticals, Inc. (SUPN) Q1 2020 Earnings Call

Concluded May 7, 2020
May 7, 2020 0 turns
Period
FY2020 Q1
Runtime
—
Sources
2 artifacts
8-K 10-Q

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Revenue $94.98M +11.1% YoY
Diluted EPS $0.40 +17.6% YoY
Net income $21.52M +17.3% YoY

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed May 7, 2020 10-Q report Filed May 15, 2020
Full-screen source Call document

SUPN transcript alerts

Supernus Pharmaceuticals, Inc.

Create a free account or sign in to receive transcript alerts at your email address.

Continue to sign in
Read transcripts like this one from Claude, ChatGPT or your own code with the earnings call transcript API →